Ergoteles LLC Enanta Pharmaceuticals Inc Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$38.82 - $54.59 $403,184 - $566,971	10,386 Added 87.45%	22,262 $900,000
Q4 2022 Feb 14, 2023	BUY	$40.77 - $53.73 $484,184 - $638,097	11,876 New	11,876 $552,000
Q2 2022 Aug 12, 2022	SELL	$38.13 - $76.93 $374,017 - $754,606	-9,809 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$56.06 - $74.11 $75,064 - $99,233	-1,339 Reduced 12.01%	9,809 $698,000
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $670,998 - $1.09 Million	11,148 New	11,148 $834,000
Q2 2021 Aug 12, 2021	SELL	$43.76 - $53.11 $498,864 - $605,454	-11,400 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$41.69 - $54.95 $475,266 - $626,430	11,400 New	11,400 $562,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.